OTC · MRMD

MariMed Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$0.07

Up+$0.00 (+3.01%)

Updated Aug 14, 2026, 9:51 AM

SID Score

4.4/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap: 29.63M
P/E ratio: -1.84
Dividend yield: 0.00%
52-week range: — – —
Volume: 104.09K
Avg. volume: 1.2M

Price performance

MRMD price history

1M range · 0 trading sessions · Daily adjusted prices

Data unavailable

The requested market data was not found.

Latest MRMD news

The latest Smart Investors Daily articles mentioning MRMD.

earningsMar 12, 2026

MariMed (MRMD) Beats Q4 Earnings Estimates by $0.02

Latest MRMD news

The latest Smart Investors Daily articles mentioning MRMD.

Stock researchResearch & News · News

Company

Overview Forecast Earnings Dividend Financials

Market Activity

Options Insider Trades Short Interest Institutional Ownership Sentiment

Research & News

Analysis Competitors News SEC Filings SID Coverage

MRMD research

News

Filterable reporting and market headlines.

Filter news

Filters are reflected in the page URL for sharing and back-button support.

MRMD news

2 matching articles.

SeekingAlpha · Aug 13, 2026

MariMed Inc. (MRMD) Q2 2026 Earnings Call Transcript

MariMed Inc. (MRMD) Q2 2026 Earnings Call August 13, 2026 8:00 AM EDTCompany ParticipantsTimothy RasmussenJon Levine - Co-Founder, CEO, President,...

Benzinga · Aug 12, 2026

MariMed Q2 Adj. EPS $(0.01), Inline, Sales $41.925M Beat $39.800M Estimate

MariMed (OTC:MRMD) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. The company reported quarterly sales of $41.925 million which beat the analyst consensus estimate of $39.800

MariMed (MRMD) Beats Q4 Earnings Estimates by $0.02

Featured By

MariMed (MRMD) Beats Q4 Earnings Estimates by $0.02